hwajin2k's profile picture. Currently at UPPThera, Cheif Operating Officer; Seoul National University, Adjunct PI
Formerly at Celltrion, Inc.
Ph.D in Cellular and Molecular Medicine, JHSOM

Hwajin Lee

@hwajin2k

Currently at UPPThera, Cheif Operating Officer; Seoul National University, Adjunct PI Formerly at Celltrion, Inc. Ph.D in Cellular and Molecular Medicine, JHSOM

You might like

Feature Selection and Dimension Reduction for Single Cell RNA-Seq based on a Multinomial Model biorxiv.org/content/10.110…


Hwajin Lee reposted

Personal News: Today marked a new beginning, and a beginning’s end. I am grateful for the support I received at @IcahnMountSinai where I started my career as an independent researcher. I am looking forward to my new role at @C2iGenomics, an innovative liquid biopsy company.


Hwajin Lee reposted

Exciting to see @KirstenKubler (now faculty at BIH @berlinnovation & @ChariteBerlin) present this recent collaborative work b/t @getz_lab and Dr. Rinath Jeselsohn on tamoxifen-associated #UterineCancer at #SABCS21! Check out the press release in her 🧵 to learn more!!

It was an honor to present our work on tamoxifen-associated #UterineCancer in #BreastCancer patients at #SABCS21. Our findings introduce a new concept that drugs can substitute for the mutant-driven activation of signaling pathways.

KirstenKubler's tweet image. It was an honor to present our work on tamoxifen-associated #UterineCancer in #BreastCancer patients at #SABCS21. Our findings introduce a new concept that drugs can substitute for the mutant-driven activation of signaling pathways.


Hwajin Lee reposted

Important study about #IMiD neosubstrate SAR with design implications for molecular glue & CRBN-targeted #PROTACs (incl. dual MoA PROTACs like KT-413, NX-2127). Of note, comprising ARV-110's magic fluorine IMiD warhead. biorxiv.org/content/10.110… @biorxivpreprint @ChoudharyLab

HartungIngo's tweet image. Important study about #IMiD neosubstrate SAR with design implications for molecular glue & CRBN-targeted #PROTACs (incl. dual MoA PROTACs like KT-413, NX-2127). Of note, comprising ARV-110's magic fluorine IMiD warhead.  biorxiv.org/content/10.110… @biorxivpreprint @ChoudharyLab
HartungIngo's tweet image. Important study about #IMiD neosubstrate SAR with design implications for molecular glue & CRBN-targeted #PROTACs (incl. dual MoA PROTACs like KT-413, NX-2127). Of note, comprising ARV-110's magic fluorine IMiD warhead.  biorxiv.org/content/10.110… @biorxivpreprint @ChoudharyLab
HartungIngo's tweet image. Important study about #IMiD neosubstrate SAR with design implications for molecular glue & CRBN-targeted #PROTACs (incl. dual MoA PROTACs like KT-413, NX-2127). Of note, comprising ARV-110's magic fluorine IMiD warhead.  biorxiv.org/content/10.110… @biorxivpreprint @ChoudharyLab
HartungIngo's tweet image. Important study about #IMiD neosubstrate SAR with design implications for molecular glue & CRBN-targeted #PROTACs (incl. dual MoA PROTACs like KT-413, NX-2127). Of note, comprising ARV-110's magic fluorine IMiD warhead.  biorxiv.org/content/10.110… @biorxivpreprint @ChoudharyLab

Hwajin Lee reposted

Kristen Baltgalvis @VividionRx @BayerPharma sharing first data for a so far untouched E3 ligase highjacked with covalent binders for bifunctional degrader applications. Further of note: cell type variability of PROTACs & E3 fractional engagement data @Undruggable #TPD21

HartungIngo's tweet image. Kristen Baltgalvis @VividionRx @BayerPharma sharing first data for a so far untouched E3 ligase highjacked with covalent binders for bifunctional degrader applications. Further of note: cell type variability of PROTACs & E3 fractional engagement data @Undruggable #TPD21
HartungIngo's tweet image. Kristen Baltgalvis @VividionRx @BayerPharma sharing first data for a so far untouched E3 ligase highjacked with covalent binders for bifunctional degrader applications. Further of note: cell type variability of PROTACs & E3 fractional engagement data @Undruggable #TPD21
HartungIngo's tweet image. Kristen Baltgalvis @VividionRx @BayerPharma sharing first data for a so far untouched E3 ligase highjacked with covalent binders for bifunctional degrader applications. Further of note: cell type variability of PROTACs & E3 fractional engagement data @Undruggable #TPD21
HartungIngo's tweet image. Kristen Baltgalvis @VividionRx @BayerPharma sharing first data for a so far untouched E3 ligase highjacked with covalent binders for bifunctional degrader applications. Further of note: cell type variability of PROTACs & E3 fractional engagement data @Undruggable #TPD21

Hwajin Lee reposted

Impressive data shared by Ryan Potts @Amgen about how they QUALITY check previously unused E3 ligases for #PROTAC applications. Clearly showing how many more ligase are still out there to be highjacked for degrading disease causing proteins. @Undruggable #TPD21

HartungIngo's tweet image. Impressive data shared by Ryan Potts @Amgen about how they QUALITY check previously unused E3 ligases for #PROTAC applications. Clearly showing how many more ligase are still out there to be highjacked for degrading disease causing proteins. @Undruggable #TPD21
HartungIngo's tweet image. Impressive data shared by Ryan Potts @Amgen about how they QUALITY check previously unused E3 ligases for #PROTAC applications. Clearly showing how many more ligase are still out there to be highjacked for degrading disease causing proteins. @Undruggable #TPD21
HartungIngo's tweet image. Impressive data shared by Ryan Potts @Amgen about how they QUALITY check previously unused E3 ligases for #PROTAC applications. Clearly showing how many more ligase are still out there to be highjacked for degrading disease causing proteins. @Undruggable #TPD21
HartungIngo's tweet image. Impressive data shared by Ryan Potts @Amgen about how they QUALITY check previously unused E3 ligases for #PROTAC applications. Clearly showing how many more ligase are still out there to be highjacked for degrading disease causing proteins. @Undruggable #TPD21

Hwajin Lee reposted

Our recent work combining in vivo CRISPR screens, E3 ligase protein degradation, and cancer immunology. Congratulations to Xiaoqing, @ShengqingGu @ctokheim and Binbin, and collaborator @maverybrown !


Hwajin Lee reposted

That @ArvinasInc ER-degrading #PROTAC ARV-471 is lenalidomide-based was one surprise. The bigger surprise is that they separated the imide epimers to provide a diastereomerically pure degrader. This question has been around for some time, but I never saw it done before. #AACR21

HartungIngo's tweet image. That @ArvinasInc ER-degrading #PROTAC ARV-471 is lenalidomide-based was one surprise. The bigger surprise is that they separated the imide epimers to provide a diastereomerically pure degrader. This question has been around for some time, but I never saw it done before. #AACR21

Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa medrxiv.org/content/10.110…


Nice works from the Sanger institute. These data, along with other pre-existing datasets, would boost researches on revealing how the somatic mutation landscape is formed during the course of normal aging and cancer progression.

Awesome two papers from Sanger on mutations in non cancerous tissues.



Hwajin Lee reposted

🔴Review about the major mutation biases that operate across the cancer genome and the molecular mechanisms that cause them. By @BenLehner @CRGenomica and @FranSupek @IRBBarcelona ➡️bit.ly/CRG_MutationsH…

"Scales and mechanisms of somatic mutation rate variation across the human genome" a Perspective in @repair_DNA, by yours truly and @BenLehner authors.elsevier.com/a/1ZnYA5aisDG3… in Cutting-edge Perspectives in Genomic Maintenance VI

FranSupek's tweet image. "Scales and mechanisms of somatic mutation rate variation across the human genome" 
a Perspective in @repair_DNA, by yours truly and @BenLehner 

authors.elsevier.com/a/1ZnYA5aisDG3…
in Cutting-edge Perspectives in Genomic Maintenance VI


Hwajin Lee reposted

A (brief) tweetorial (@CharlesSwanton request) for our latest work - Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia nature.com/articles/s4158…


Analyzing these types of data would also reveal how the environmental agents intertwine with the chromatin landscape or other factors associated with the mutation accumulation patterns for normal tissues and cells. cell.com/cell/fulltext/…


Great work with really nice presentation!

Thanks #AACR2019 for the opportunity to present our #PanCancer #Study of #Cancer #CellOfOrigin. It is a privilege of working with @rosa2003, Will Foulkes, @PolakPaz and @gaddyg. In case you missed my talk, the whole story can be found here: biorxiv.org/content/10.110… @broadinstitute

KirstenKubler's tweet image. Thanks #AACR2019 for the opportunity to present our #PanCancer #Study of #Cancer #CellOfOrigin. It is a privilege of working with @rosa2003, Will Foulkes, @PolakPaz and @gaddyg. In case you missed my talk, the whole story can be found here: biorxiv.org/content/10.110…
@broadinstitute
KirstenKubler's tweet image. Thanks #AACR2019 for the opportunity to present our #PanCancer #Study of #Cancer #CellOfOrigin. It is a privilege of working with @rosa2003, Will Foulkes, @PolakPaz and @gaddyg. In case you missed my talk, the whole story can be found here: biorxiv.org/content/10.110…
@broadinstitute


Apparently this would be more of a underrated issue for some of the minorities. Hope much more genomics data from Asian and other races would come out and get attentions by scientific and medical communities.

Increasing diversity in all forms of scientific research important!! Genetic research has a white bias, and it may be hurting everyone's health - PBS NewsHour apple.news/A7c3FYK7OQ_Kv5…



United States Trends

Loading...

Something went wrong.


Something went wrong.